Phase I Treatment of Adults With Primary Malignant Glioma With Irinotecan (CPT-11) (NSC 6616348) Plus BCNU [carmustine] (NSC 409962).
Phase of Trial: Phase I
Latest Information Update: 19 Feb 2013
At a glance
- Drugs Carmustine (Primary) ; Irinotecan (Primary)
- Indications Glioma
- Focus Adverse reactions
- 13 Dec 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 20 Sep 2005 New trial record.